approval · primary record
VEDOLIZUMAB
FDA · BLA · 2026-02-25
| Agency | FDA |
|---|---|
| Submission type | BLA |
| Action date | 2026-02-25 |
| Brand | ENTYVIO |
| Sponsor | TAKEDA PHARMS USA |
| Route | INTRAVENOUS |
Provenance
- Source: openFDA Drugs@FDA
- Fetched at: 2026-10-28T02:35:11.664Z
- Licence class: public-domain
- Verdict: primary-source
- Entity id: FDA:VEDOLIZUMAB:2026-02-25
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.